Cardiac intensive care

Introduction Frontmatter Front Matter Copyright Dedication Foreword Preface Contributors Section I - Introduction , CHAPTER 1 - Evolution of the Coronary Care Unit: Past, Present, and Future , CHAPTER 2 - Ethical Issues of Care in the Cardiac Intensive Care Unit , CHAPTER 3 - Cardiac Intensive Care Unit Admission Criteria , CHAPTER 4 - Physical Examination in the Cardiac Intensive Care Unit Section II - Scientific Foundation of Cardiac Intensive Care , CHAPTER 5 - Role of the Cardiovascular System in Coupling the External Environment to Cellular Respiration , CHAPTER 6 - Regulation of Cardiac Output , CHAPTER 7 - Coronary Physiology and Pathophysiology , CHAPTER 8 - Pathophysiology of Acute Coronary Syndromes: Plaque Rupture and Atherothrombosis , CHAPTER 9 - Regulation of Hemostasis and Thrombosis Section III - Coronary Artery Disease , Acute Myocardial Infarction , Complications of Acute Myocardial Infarction , Complications of Percutaneous Interventional Procedures Section IV - Noncoronary Diseases: Diagnosis and Management , CHAPTER 24 - Acute Heart Failure and Pulmonary Edema , CHAPTER 25 - Sudden Cardiac Death , CHAPTER 26 - Pacemaker and Implantable Cardioverter-Defibrillator Emergencies , CHAPTER 27 - Acute Presentations of Valvular Heart Disease , CHAPTER 28 - Hypertensive Emergencies , CHAPTER 29 - Acute Aortic Syndromes: Diagnosis and Management , CHAPTER 30 - Pericardial Disease , CHAPTER 31 - Acute Respiratory Failure , CHAPTER 32 - Massive Acute Pulmonary Embolism , CHAPTER 33 - Pulmonary Hypertension , CHAPTER 34 - Hemodynamically Unstable Presentations of Congenital Heart Disease in Adults , CHAPTER 35 - Overdose of Cardiotoxic Drugs Section V - Pharmacologic Agents in the CICU , CHAPTER 36 - Anticoagulation: Antithrombin Therapy , CHAPTER 37 - Antiplatelet Therapy , CHAPTER 38 - Inotropic and Vasoactive Agents in the Cardiac Intensive Care Unit , CHAPTER 39 - Diuretics and Newer Therapies for Sodium and Edema Management in Acute Decompensated Heart Failure , CHAPTER 40 - Antiarrhythmic Electrophysiology and Pharmacotherapy , CHAPTER 41 - Analgesics, Tranquilizers, and Sedatives , CHAPTER 42 - Pharmacologic Interactions in the CICU Section VI - Advanced Diagnostic and Therapeutic Techniques: Indications and Technical Considerations , CHAPTER 43 - Echocardiography in the CICU , CHAPTER 44 - Vascular Access in the Intensive Care Unit , CHAPTER 45 - Invasive Hemodynamic Monitoring in the Cardiac Intensive Care Unit , CHAPTER 46 - Intra-Aortic Balloon Pump Counterpulsation , CHAPTER 47 - Ventricular Assist Device Therapy in Advanced Heart Failure—State of the Art , CHAPTER 48 - Cardiac Transplantation , CHAPTER 49 - Emergency Airway Management , CHAPTER 50 - Mechanical Ventilation in the Cardiac Care Unit , CHAPTER 51 - Emergency Dialysis and Ultrafiltration , CHAPTER 52 - Cardiocerebral Resuscitation, Defibrillation, and Cardioversion APPENDIX 1: Color Key to ACC/AHA Management Guidelines: Estimate of Certainty (Precision) of Treatment Effect APPENDIX 2: ACC/AHA Guidelines for Primary Percutaneous Coronary Intervention of ST Segment Elevation Acute Myocardial Infarction APPENDIX 3: ACC/AHA Guidelines for Early Hospital Care of Patients with Unstable Angina/Non-ST Segment Elevation Myocardial Infarction A Anti-ischemic and Analgesic Therapy B Antiplatelet Therapy C Anticoagulant Therapy APPENDIX 4: ACC/AHA Guidelines for the Management of Chronic Heart Failure A Patients at High Risk for Developing Heart Failure (Stage A) B Patients with Cardiac Structural Abnormalities or Remodeling Who Have Not Developed Heart Failure Symptoms (Stage B) C Patients with Current or Prior Symptoms of Heart Failure (Stage C) D Patients with Refractory End-Stage Heart Failure (Stage D)